Australian Clinical Labs
ACL.AX
#7265
Rank
โ‚น31.33 B
Marketcap
โ‚น157.67
Share price
-1.67%
Change (1 day)
8.09%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2024: โ‚น39.43 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น39.43 Billion. In 2024 the company made a revenue of โ‚น39.43 Billion an increase over the revenue in the year 2023 that were of โ‚น39.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2024

Annual revenue

Year Revenue Change
2024โ‚น39.43 B0.76%
2023โ‚น39.13 B-32.69%
2022โ‚น58.14 B41.26%
2021โ‚น41.16 B